We are pleased to announce that the Vienna Science and Technology Fund (WWTF) has awarded funding to the MetPredict consortium under the Life Sciences programme (LS23-067). This grant will support our interdisciplinary research into predicting metastatic potential in breast cancer.
The project brings together expertise in tumor biology, computational pathology, and clinical diagnostics from three research groups at the Medical University of Vienna and CeMM. More details on our research aims and team will follow soon.